Cipher Pharmaceuticals Inc. (TSE:CPH – Get Free Report) (NASDAQ:CPHR) Director Harold Morton Wolkin sold 3,500 shares of the company’s stock in a transaction on Monday, March 24th. The shares were sold at an average price of C$13.49, for a total transaction of C$47,215.00.
Cipher Pharmaceuticals Trading Down 3.3 %
Shares of TSE CPH traded down C$0.44 during midday trading on Monday, reaching C$12.70. The stock had a trading volume of 18,709 shares, compared to its average volume of 36,476. The firm has a market cap of C$228.01 million, a price-to-earnings ratio of 14.03 and a beta of 1.20. The company’s 50 day moving average price is C$12.91 and its 200 day moving average price is C$14.46. Cipher Pharmaceuticals Inc. has a twelve month low of C$7.90 and a twelve month high of C$19.69. The company has a debt-to-equity ratio of 41.22, a quick ratio of 2.67 and a current ratio of 2.00.
Cipher Pharmaceuticals Company Profile
Recommended Stories
- Five stocks we like better than Cipher Pharmaceuticals
- What is a Bond Market Holiday? How to Invest and Trade
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Which Wall Street Analysts are the Most Accurate?
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- What Is WallStreetBets and What Stocks Are They Targeting?
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.